Advancement of Autogenous Vaccines in the Poultry Industry.

Autogenous vaccines, also known as "custom" vaccines, have become an essential instrument in the production veterinarian's toolbox for the control of emerging and evolving diseases. Autogenous vaccines require a reduced burden of U.S. Department of Agriculture licensing, making them rapidly accessible. Autogenous vaccines have made significant advancements in the ability to reduce disease within the poultry industry from a combination of several different advancements in regulation requirements, rapid and accurate diagnostic assessments, and improvements in manufacturing. The use of autogenous vaccines by poultry health professionals has also increased, and these custom-made products have been instrumental in combating diseases resulting from antigenic variants such as salmonellosis, colibacillosis, infectious coryza, infectious bursal disease, inclusion body hepatitis, viral enteritis, and viral arthritis and tenosynovitis.

Estudio recapitulativo- Avance de las vacunas autógenas en la industria avícola Las vacunas autógenas, también conocidas como vacunas "personalizadas, elaboradas de acuerdo con las necesidades del cliente" ("custom"), se han convertido en un instrumento esencial en el inventario de herramientas del veterinario de producción para el control de enfermedades emergentes y en evolución. Las vacunas autógenas requieren un procedimiento reducido para obtener la licencia por parte del Departamento de Agricultura de los Estados Unidos, lo que las hace rápidamente accesibles. Las vacunas autógenas han logrado avances significativos en la capacidad de reducir enfermedades dentro de la industria avícola gracias a una combinación de varios avances diferentes en los requisitos regulatorios, evaluaciones de diagnóstico rápidas y precisas y mejoras en la fabricación. También ha aumentado el uso de vacunas autógenas por parte de los profesionales de la salud avícola, y estos productos hechos a medida han sido fundamentales para combatir enfermedades resultantes de variantes antigénicas como la salmonelosis, la colibacilosis, la coriza infecciosa, la enfermedad infecciosa de la bolsa, hepatitis con cuerpos de inclusión, la enteritis viral y la artritis y tenosinovitis virales.

Synthesis of surgeon and rehabilitation therapist treatment methods of bicipital tenosynovitis in dogs allows development of an initial consensus therapeutic protocol.

OBJECTIVE: To compare the therapeutic approach of surgical specialists, sports medicine and rehabilitation specialists, and veterinarians with rehabilitation certification when treating bicipital tendon disease or tenosynovitis in dogs and to combine this information with existing research to develop a treatment algorithm that provides a framework for treating bicipital tenosynovitis. SAMPLE: 223 respondents to an internet survey of board-certified veterinary surgeons, board-certified sports medicine and rehabilitation therapists, and veterinarians with rehabilitation certification. METHODS: The survey was promoted via multiple listservs, specialist college newsletters, and private relevant social media sites. Answers were compiled and submitted for statistical analysis. RESULTS: Compared to rehabilitation therapists (RTh), surgeons placed less value on the stabilizing function of the biceps tendon and its role in preventing other shoulder morbidities. Similarly, compared to RTh, surgeons were more inclined to select surgery as the primary therapeutic approach and attributed a less optimistic prognosis to conservative therapy outcomes. There were multiple differences between surgeons and RTh in executing a conservative therapy program, with RTh more likely to recommend therapeutic exercise, extracorporeal shockwave, regenerative medicine, therapeutic ultrasound, exercise restriction, photobiomodulation, and pulsed electromagnetic field therapy. RTh were less likely to prescribe NSAIDS or inject corticosteroids. Despite the above noted differences, there were also multiple areas of agreement. CLINICAL RELEVANCE: Consensus agreement, combined with existing research, was used to create a treatment algorithm suggesting how to best address multiple manifestations of bicipital tendinopathy. Such guidelines can be considered to direct therapeutic strategies for this common condition.

Genetic characterization of newly emerging avian reovirus variants in chickens with viral arthritis/tenosynovitis in Israel.

In recent years, new avian reovirus (ARV) variants caused a variety of symptoms in chickens worldwide, the most important of which was Viral arthritis/tenosynovitis which caused substantial economic losses and has become a concern to the worldwide chicken industry. In this study, we characterized emerging ARV variants in Israel and analyzed their genetic relationship with reference strains. One hundred thirty-four ARV variants were isolated from tendons and synovial fluids of commercial broiler chickens with signs of arthritis/tenosynovitis. Phylogenetic analysis of the partial segment of the sigma C (σC) gene confirmed that these field isolates from Israel could be clustered into all six known clusters. The majority of ARV isolates in Israel belonged to the genotypic cluster 5 (GC5). The strains in this study had a low sequence identity when compared to the commercial vaccine (strain S1133). The findings of this study demonstrated the genetic diversity of ARV strains in Israel from 2015 to 2022. It is reasonable to conclude from the preliminary results of this investigation that Israel has not been subject to selection pressure or the emergence of new ARV variants since the introduction of the live vaccine (ISR-7585). Due to the ongoing emergence of ARV variants, a robust epidemiological monitoring program supported by molecular biology techniques is required to track ARV strains in Israeli poultry flocks.

Proliferative tenosynovitis in Brazilian Mangalarga Marchador horses.

Proliferative tenosynovitis (PT) is an inflammatory and proliferative disorder of the synovial membrane of the tendon sheath that is rare in animals. The histological alterations are characterized by multinodular neovascularization, with infiltration of histiocytic and multinucleated giant cells and haemosiderin deposition. We reviewed necropsy and biopsy records of horses submitted to the Setor de Anatomia Patológica of the Universidade Federal Rural do Rio de Janeiro from January 2017 to December 2020 to select cases of PT. We identified PT in three adult Brazilian Mangalarga Marchador horses with nodular lesions on the metacarpophalangeal, metatarsophalangeal or carpal joints. The three horses were under 6 years of age and presented with lameness and pain on palpation. There were recurrences in two horses after surgical removal. Radiographic and ultrasound examinations detected masses in the flexor or extensor tendons and subtendinous bursa. Histological study of synovial membrane and tendon sheath revealed an increased number of vessels, fibroplasia, osseous metaplasia and infiltration of lymphocytes, plasma cells and siderophages. This is the first description of PT in horses, which should be included as an orthopaedic differential diagnosis, especially in Mangalarga Marchador horses with lameness.

Treatment of Septic Tenosynovitis and Osteoarthritis in an American White Pekin (Anas platyrhynchos domesticus) with Repeated Intravenous Regional Limb Perfusion and Antibiotic-Impregnated Calcium Sulfate Beads.

A 2-year-old female American white pekin (Anas platyrhynchos domesticus) was assessed for a 2-month history of chronic lameness and swelling involving the left leg. Radiographic images of the left leg showed soft tissue swelling of the digits and tarsometatarsus with osteolysis of the tarsometatarsal-phalangeal joint. A complete blood count revealed marked leukocytosis and hyperproteinemia. A Streptococcus species was isolated from a bacterial culture of fluid obtained from the left tarsometatarsal-phalangeal joint. Biweekly intravenous regional limb perfusions of the left leg with ampicillin-sulbactam and amikacin were performed on the patient. Despite initial improvement in left leg lameness and swelling, follow-up radiographic images showed progressive osteolysis of the tarsometatarsal-phalangeal joint and associated digits. Surgical placement of antibiotic-impregnated calcium sulfate beads into the left tarsometatarsal-phalangeal joint was next performed with concurrent, repeated intravenous regional limb perfusion using the same antibiotic. Following the placement of antibiotic-impregnated beads and continued intravenous regional limb perfusion, the duck had decreased lameness and swelling of the left leg. Repeated antibiotic treatment through intravenous regional limb perfusion and concurrent placement of antibiotic-impregnated calcium sulfate beads is a practical treatment option for complicated distal limb infections in avian species. This therapeutic protocol has great potential in treating aggressive distal leg infections in many avian species because regional limb perfusion alone may not penetrate the joint adequately to achieve complete resolution of infection.

Avian Reovirus σA Protein Inhibits Type I Interferon Production by Abrogating Interferon Regulatory Factor 7 Activation.

Type I interferon (IFN) response is the first line of host-based innate immune defense against viral infections. However, viruses have developed multiple strategies to counter host IFN responses, so they may continue infecting hosts via effective replication. Avian reovirus (ARV), an RNA virus, causes viral arthritis or tenosynovitis in chickens. Previous studies have shown that ARV is highly resistant to the antiviral effects of IFN. However, the underlying mechanisms that enable ARV to block the IFN pathway remain unclear. In this study, we found that ectopic expression of ARV protein, σA, significantly inhibited the production of IFN-ß induced by melanoma-differentiation-associated gene 5 (MDA5) and poly(I·C). Knockdown of σA during ARV infection enhances the IFN-ß response and suppresses viral replication. ARV σA inhibited the MDA5-mediated IFN-ß activation by targeting interferon regulatory factor 7 (IRF7). Further studies demonstrated that σA interacts with IRF7, thereby blocking IRF7 dimerization and nuclear translocation, finally leading to the inhibition of IFN-ß production. These findings reveal a novel mechanism that allows ARV to evade host antiviral immunity. IMPORTANCE ARV, the causative agent of viral arthritis or tenosynovitis in chickens, has a significant economic impact as it results in poor weight gain and increased feed conversion ratios. The MDA5-mediated IFN-ß signal pathway plays an important role in host antiviral defense. Therefore, RNA viruses have developed mechanisms to counter this signaling pathway and successfully establish infection. However, the strategies adopted by ARV to block MDA5-IRF7 signaling remain unclear. In the current study, we demonstrated that ARV σA inhibits this pathway by binding to IRF7, which blocked IRF7 dimerization and nuclear translocation. Our findings may provide insights into how avian reovirus counteracts the innate antiviral immunity of the host to ensure viral replication.

Diagnosis and outcome following tenoscopic surgery of the digital flexor tendon sheath in German sports and pleasure horses.

BACKGROUND: Digital flexor tendon sheath (DFTS) pathology is an important cause of lameness in horses. The outcome after surgical treatment is variable and depends on the exact diagnosis. OBJECTIVES: To (1) describe the prevalence of lesions associated with lameness caused by nonseptic DFTS tenosynovitis in a large population of German sports and pleasure horses; (2) determine the sensitivity and specificity of diagnostic imaging techniques for identifying lesions within the DFTS with tenoscopic diagnosis being the gold standard; (3) explore associations between tenoscopically diagnosed lesions and signalment, purpose, and limb affected; and (4) describe the outcome following DFTS tenoscopy with nonseptic DFTS tenosynovitis in this population. STUDY DESIGN: Retrospective case series. METHODS: Medical records of horses admitted for tenoscopic surgery of nonseptic DFTS tenosynovitis between 2011 and 2020 were reviewed. Follow-up information was obtained via telephone contact. Sensitivity and specificity of ultrasonography and contrast tenography were determined using tenoscopic diagnosis as gold standard and univariable analysis was used to explore associations between signalment, case history, and tenoscopic diagnosis. RESULTS: Medical records from 131 horses were retrieved, of which 8 horses had bilateral disease and 6 horses were presented for tenoscopy on two separate occasions (3 for tenoscopy in the same limb, 3 in a different limb), thus, making a total of 145 limbs. Lesions were most commonly diagnosed in the deep (DDFT; n = 55 limbs) and superficial (SDFT; n = 55 limbs) digital flexor tendons. Manica flexoria (MF) lesions were detected in 44 limbs and palmar/plantar annular ligament (PAL) constriction in 99 limbs. In 36 limbs, only one structure within the DFTS was injured, whereas in 109 limbs a combination of lesions was noted, the most common being the combination of a SDFT lesion with PAL constriction. All affected limbs were examined with diagnostic ultrasonography; contrast tenography was performed in 86 limbs. For diagnosis of MF and DDFT tears, tenography was more sensitive (89% [confidence interval, CI: 65.4%-95.2%]; 72% [CI: 46.4%-89.3%], respectively) than specific (64% [CI: 52.5%-77.6%]; 53% [CI: 42.2%-73.3%], respectively) whereas ultrasonography was more specific (92% [CI: 84.5%-96.3%]; 92% [CI: 83.6%-96.0%]) with lower sensitivity (64% [CI: 47.7%-77.2%]; 54% [CI: 39.5%-67.9%]). For SDFT lesions, ultrasonography was highly specific (94% [CI: 86.9%-97.9%]) with lower sensitivity (66% [CI: 51.3%-77.4%]). Follow-up information following first surgery was obtained for 118 horses (132 limbs): 18 (15.3%) of 118 horses remained chronically lame, 40 (33.8%) performed at a reduced level and 60 (50.8%) performed at the same or higher level following rehabilitation after tenoscopy. Horses with DDFT lesions had the poorest outcomes with only 36.6% returning to the same or higher level of exercise. MAIN LIMITATIONS: Retrospective analysis of clinical records and subjective outcome assessment based on owner follow-up with potential recall bias. Findings on diagnostic imaging are impacted by many factors including equipment quality and operator expertise and experience. CONCLUSION: Diagnostic imaging techniques were complimentary and contrast tenography was sensitive and ultrasonography was specific for the diagnosis of MF and DDFT lesions. Following tenoscopic surgery for nonseptic tenosynovitis of the DFTS, approximately half the cases were able to return to preinjury level of exercise.

Comparative pathogenesis of turkey reoviruses.

Turkey reoviruses have been implicated in multiple disease syndromes resulting in significant economic losses to the turkey industry. It has been known for decades that turkey enteric reovirus (TERV) is involved in poult enteritis complex, but turkey arthritis reovirus (TARV), the causative agent of tenosynovitis in turkeys, emerged in 2011. In 2019, we isolated reovirus from several cases of hepatitis in turkeys and tentatively named it turkey hepatitis reovirus (THRV). The comparative pathogenesis of these viruses, and correlation with their genetic make-up (if any), is not known. In this study, we inoculated nine groups of 1-week-old turkey poults with two THRV, five TARV and two TERV via oral route. A tenth group served as a negative control. A subset of birds from each group was euthanised at 3, 5, 7, 14, 21, and 28 days post-inoculation (dpi). Tissues were collected for histology and real-time RT-PCR. All nine viruses were found to be enterotropic; the virus gene copy number in the intestine reached a peak at 5 dpi followed by a sharp decline at 7 dpi. All viruses caused a significant decline in body weight gain of birds as compared to the negative control group. Both TARV and THRV strains replicated in tendons and produced histologic lesions consistent with tenosynovitis. Hepatic lesions were produced by THRV only and the virus was re-isolated from liver and spleen of inoculated birds fulfilling Koch's postulates. The results of this study should be helpful in facilitating diagnosis and designing future mitigation plans.

Avian Reoviruses from Clinical Cases of Tenosynovitis: An Overview of Diagnostic Approaches and 10-Year Review of Isolations and Genetic Characterization.

Reoviral-induced tenosynovitis/viral arthritis is an economically significant disease of poultry. Affected birds present with lameness, unilateral or bilateral swollen hock joints or shanks, and/or reluctance to move. In severe cases, rupture of the gastrocnemius or digital flexor tendons may occur, and significant culling may be necessary. Historically, vaccination with a combination of modified live and inactivated vaccines has successfully controlled disease. Proper vaccination reduced vertical transmission and provided maternal-derived antibodies to progeny to protect against disease, at an age when they were most susceptible. Starting in 2011-2012, an increased incidence of tenosynovitis/viral arthritis was observed in chickens and turkeys. In chickens, progeny from reovirus-vaccinated breeders were affected, suggesting commercial vaccines did not provide adequate protection against disease. In turkeys, clinical disease was primarily in males, although females can also be affected. The most significant signs were observed around 14-16 wks of age and include reluctance to move, lameness, and limping on one or both legs. The incidence of tenosynovitis/viral arthritis presently remains high. Reoviruses isolated from clinical cases are genetically and antigenically characterized as variants, meaning they are different from vaccine strains. Characterization of the field isolates reveals multiple new genotypes and serotypes that are significantly different from commercial vaccines and each other. In 2012, a single prevalent virus was isolated from a majority of the cases submitted to the Poultry Diagnostic and Research Center at the University of Georgia. Genetic characterization of the σC protein revealed the early isolates belonged to genetic cluster (GC) 5. Soon after the initial identification of the GC5 variant reovirus, many broiler companies incorporated these isolates from their farms into their autogenous vaccines and continue to do so today. The incidence of GC5 field isolates has decreased significantly, likely because of the widespread use of the isolates in autogenous vaccines. Unfortunately, variant reoviruses belonging to multiple GCs have emerged, despite inclusion of these isolates in autogenous vaccines. In this review, an overview of nomenclature, sample collection, and diagnostic testing will be covered, and a summary of variant reoviruses isolated from clinical cases of tenosynovitis/viral arthritis over the past 10 yrs will be provided.

Estudio recapitulativo- Reovirus aviares de casos clínicos de tenosinovitis: una descripción general de los enfoques de diagnóstico y una revisión de 10 años de aislamientos y caracterización genética. La tenosinovitis/artritis viral inducida por reovirus es una enfermedad económicamente significativa de la avicultura. Las aves afectadas presentan cojera, articulaciones de corvejones o patas inflamadas unilateral o bilateralmente y/o renuencia a moverse. En casos severos, puede ocurrir la ruptura de los tendones del gastrocnemio o del flexor digital, y puede ser necesario una eliminación de aves afectadas significativa. Históricamente, la vacunación con una combinación de vacunas vivas modificadas e inactivadas ha controlado con éxito la enfermedad. La vacunación adecuada redujo la transmisión vertical y proporcionó anticuerpos derivados de las reproductoras a la progenie para protegerlos contra la enfermedad, a una edad en la que eran más susceptibles. A partir de los años 2011-2012, se observó una mayor incidencia de tenosinovitis/artritis viral en pollos y pavos. En los pollos, la progenie de reproductores vacunados con reovirus se vio afectada, lo que sugiere que las vacunas comerciales no brindaron una protección adecuada contra la enfermedad. En pavos, la enfermedad clínica fue principalmente en machos, aunque las hembras también pueden verse afectadas. Los signos más significativos se observaron alrededor de las 14 a 16 semanas de edad e incluyen renuencia a moverse y cojera en una o ambas piernas. La incidencia de tenosinovitis/artritis viral actualmente sigue siendo alta. Los reovirus aislados de casos clínicos se caracterizan genética y antigénicamente como variantes, lo que significa que son diferentes de las cepas vacunales. La caracterización de los aislamientos de campo revela múltiples genotipos y serotipos nuevos que son significativamente diferentes de las vacunas comerciales y entre sí. En 2012, se aisló un solo virus prevalente de la mayoría de los casos presentados al Centro de Investigación y Diagnóstico Avícola de la Universidad de Georgia. La caracterización genética de la proteína sigma C reveló que los primeros aislamientos pertenecían al grupo genético 5 (GC5). Poco después de la identificación inicial de la variante GC5 del reovirus, muchas empresas de pollos de engorde incorporaron estos aislamientos de sus granjas en sus vacunas autógenas y continúan haciéndolo en la actualidad. La incidencia de aislamientos de campo de GC5 ha disminuido significativamente, probablemente debido al uso generalizado de los aislamientos en vacunas autógenas. Desafortunadamente, han surgido variantes de reovirus que pertenecen a múltiples grupos genéticos, a pesar de la inclusión de estos aislados en vacunas autógenas. En esta revisión, se cubrirá una descripción general de la nomenclatura, la recolección de muestras y las pruebas de diagnóstico, y se brindará un resumen de las variantes de reovirus aisladas de casos clínicos de tenosinovitis/artritis viral durante los últimos 10 años.

Field Control of Avian Reoviruses in Commercial Broiler Production.

Prevention of tenosynovitis/viral arthritis caused by variant avian reoviruses within commercial broiler production has become increasingly more challenging because of the lack of protection afforded by the current commercially available vaccines. Avian reoviruses isolated from clinical cases of tenosynovitis/viral arthritis in recent years are antigenically distinct from nearly all of the commercially licensed modified live and inactivated biologics available in the United States. The emergence of new variants is likely shaped by a lack of homologous protection coupled with selection pressure influences and results in antigenically diverse populations of avian reoviruses. One tool available to the poultry industry is the use of autogenous (custom) vaccines. Although these can be effective, isolation, characterization, and screening of isolates from clinical cases is paramount for the selection of isolates to include in these vaccines. With no treatment options, control can only be attained via prevention of infection. To achieve this goal, commercially licensed products with antigenic applicability and broadly cross-protective vaccine strains are needed.

Estudio recapitulativo- Control de campo de los reovirus aviares en la producción comercial de pollos de engorde. La prevención de la tenosinovitis/artritis viral causada por variantes de reovirus aviares dentro de la producción comercial de pollos de engorde se ha vuelto cada vez más difícil debido a la falta de protección que brindan las vacunas disponibles comercialmente en la actualidad. Los reovirus aviares aislados de casos clínicos de tenosinovitis/artritis viral en los últimos años son antigénicamente distintos de casi todos los biológicos vivos modificados e inactivados con licencia y disponibles comercialmente en los Estados Unidos. La aparición de nuevas variantes probablemente se deba a la falta de protección homóloga junto con las influencias de la presión de selección y da como resultado poblaciones antigénicamente diversas de reovirus aviares. Una herramienta disponible para la industria avícola es el uso de vacunas autógenas (elaboradas de acuerdo a los virus de cada compañía). Si bien estos pueden ser efectivos, el aislamiento, la caracterización y la detección de aislamientos de casos clínicos son de suma importancia para la selección de aislamientos para incluir en estas vacunas. Sin opciones de tratamiento, el control solo se puede lograr a través de la prevención de la infección. Para lograr este objetivo, se necesitan productos comercialmente autorizados con aplicabilidad antigénica y cepas de vacunas que induzcan protección cruzada amplia.

Evaluation of Pathogenicity and Antigenicity of Avian Reoviruses and Disease Control Through Vaccination.

Avian reoviruses are ubiquitous in poultry production worldwide and can be transmitted vertically or horizontally among chickens. The pathogenicity of reoviruses can range from very pathogenic viruses that affect multiple tissues and organs to apathogenic. Avian reoviruses have been associated with many disease presentations, and two of the most economically significant diseases are viral arthritis/tenosynovitis and viral enteritis. Viral arthritis/tenosynovitis has been recognized since the 1950s and essentially disappeared after development of attenuated live and inactivated vaccines in the 1980s but re-emerged in 2011 due to the emergence of antigenic variants. Viral enteritis was first recognized in the 1970s and became the predominant reovirus-associated disease between 2006 and 2011 due to the emergence of pathogenic enterotropic reoviruses. Pathogenicity of reovirus isolates can be evaluated in several ways, including inoculation of day-old broiler chicks with low maternal reovirus antibody titers via the foot pad route or the oral and intratracheal route. Pathogenic reoviruses induce foot pad inflammation within 3 days of inoculation, and more pathogenic reoviruses are able to disseminate to and damage visceral organs. Only reovirus infections in young chickens result in disease due to age-related resistance to disease development. Reoviruses exist as many serotypes and subtypes with various degrees of interrelatedness. The earliest reovirus strains in the United States were antigenically related to each other and are referred to as S1133-like viruses, but in the 2000s, reoviruses emerged that were antigenically different from the S1133-like viruses. Virus neutralization assay using polyclonal antisera has been used to classify the emerging variant reoviruses into serogroups. The first reovirus vaccines were developed in the 1970s, and by the 1980s breeder vaccination programs were established that protected breeders, prevented vertical transmission of reovirus, and provided maternal immunity to the progeny during the crucial first 3 wk of life. With the emergence of antigenic variant reoviruses in the 2000s, vaccination programs using S1133-like vaccines became ineffective. The poultry industry has relied on vaccination with autogenous inactivated reovirus vaccines to alleviate losses due to viral arthritis/tenosynovitis and viral enteritis. Virus isolates used for autogenous vaccines must be updated regularly and are selected based on pathotype, serotype, or Sigma C (σC) genotype. Live attenuated S1133 vaccines are still used in breeder chickens for the priming effect, followed by one or more injections of the inactivated licensed and/or autogenous vaccines. The route of vaccination and the number of doses received by breeder chickens are very important for a sufficient antibody response. Intramuscular vaccination with inactivated vaccines elicits the highest antibody response, while subcutaneous vaccination with inactivated vaccines elicits a low antibody response. More recently, research has focused on development of alternative vaccines and vaccination strategies. An inactivated variant reovirus vaccine was developed that elicits protection against multiple variant serotypes, and experimental recombinant and subunit vaccines have been described and show potential. More research needs to be done to develop better vaccines, vaccination programs, and other control measures for preventing reovirus infection, transmission, and losses due to disease.

Estudio recapitulativo- Evaluación de patogenicidad y antigenicidad de reovirus aviares y control de enfermedades mediante vacunación Los reovirus aviares son ubicuos en la producción avícola en todo el mundo y pueden transmitirse por vías vertical u horizontal entre los pollos. La patogenicidad de los reovirus puede variar desde virus muy patógenos que afectan múltiples tejidos y órganos hasta virus apatógenos. Los reovirus aviares se han asociado con muchas presentaciones de enfermedades, y dos de las enfermedades más significativas desde el punto de vista económico son la artritis/tenosinovitis viral y la enteritis viral. La artritis/tenosinovitis viral se ha reconocido desde la década de 1950 y esencialmente desapareció después del desarrollo de vacunas vivas atenuadas e inactivadas en la década de 1980, pero resurgió en 2011 debido a la aparición de variantes antigénicas. La enteritis viral se reconoció por primera vez en la década de 1970 y se convirtió en la enfermedad predominante asociada a reovirus entre 2006 y 2011 debido a la aparición de reovirus enterotrópicos patógenos. La patogenicidad de los aislados de reovirus se puede evaluar de varias maneras, incluida la inoculación de pollos de engorde de un día con títulos bajos de anticuerpos maternos contra el reovirus a través de la vía del cojinete almohadilla plantar o la vía oral e intratraqueal. Los reovirus patógenos inducen la inflamación de las almohadillas de las patas dentro de los tres días posteriores a la inoculación, y más reovirus patógenos pueden diseminarse y dañar los órganos viscerales. Solo las infecciones por reovirus en pollos jóvenes resultan en enfermedades debido a la resistencia relacionada con la edad al desarrollo de la enfermedad. Los reovirus existen como muchos serotipos y subtipos con varios grados de interrelación. Las primeras cepas de reovirus en los Estados Unidos estaban relacionadas antigénicamente entre sí y se conocen como virus relacionados a la cepa S1133, pero en la década de 2000 surgieron reovirus que eran antigénicamente diferentes de los virus relacionados con S1133. Se ha utilizado el ensayo de neutralización de virus con antisueros policlonales para clasificar las variantes de reovirus emergentes en serogrupos. Las primeras vacunas contra el reovirus se desarrollaron en la década de 1970, y en la década de 1980 se establecieron programas de vacunación para reproductores que protegían a los reproductores, prevenían la transmisión vertical de reovirus y proporcionaban inmunidad materna a la progenie durante las cruciales primeras tres semanas de vida. Con la aparición de variantes antigénicas de reovirus en la década de 2000, los programas de vacunación con vacunas relacionadas con la cepa S1133 se volvieron ineficaces. La industria avícola se ha basado en la vacunación con vacunas autógenas de reovirus inactivado para aliviar las pérdidas debidas a artritis/tenosinovitis viral y enteritis viral. Los aislados de virus utilizados para las vacunas autógenas deben actualizarse con regularidad y se seleccionan según el patotipo, el serotipo o el genotipo Sigma C (σC). Las vacunas vivas atenuadas S1133 todavía se usan en pollos reproductores para el efecto de preparación, seguidas de una o más inyecciones de las vacunas inactivadas autorizadas y/o autógenas. La vía de vacunación y el número de dosis recibidas por los pollos reproductores son muy importantes para una respuesta de anticuerpos suficiente. La vacunación intramuscular con vacunas inactivadas provoca la mayor respuesta de anticuerpos, mientras que la vacunación subcutánea con vacunas inactivadas provoca una baja respuesta de anticuerpos. Más recientemente, la investigación se ha centrado en el desarrollo de vacunas alternativas y estrategias de vacunación. Se desarrolló una vacuna de reovirus variante inactivada que provoca protección contra múltiples serotipos variantes, y se han descrito vacunas experimentales recombinantes y de subunidades que muestran potencial. Se necesita más investigación para desarrollar mejores vacunas, programas de vacunación y otras medidas de control para prevenir la infección, transmisión y pérdidas por reovirus debido a la enfermedad.

Emerging new avian reovirus variants from cases of enteric disorders and arthritis/tenosynovitis in Brazilian poultry flocks.

1. The objective of this study was to characterise circulating Brazilian avian reovirus (ARV) strains by genetic analysis of the σC protein encoded by segment 1 of the viral genome and compare these with those of viral strains used for immunising commercial poultry.2. The analysis detected the presence of ARV genomes by quantitative reverse transcriptase PCR (RT-qPCR) in the enteric samples and the joint tissues (JT) of birds with signs of viral arthritis/tenosynovitis. Nucleotide sequencing used 16 strains (three commercial vaccines, 10 from enteric tissues and three from JT). The results indicated high variability in the amino acid sequences of 13 wild strains, showing between 40% and 75% similarity compared with the vaccine strains (S1133 and 2177).3. The sequences were grouped into three well-defined clusters in a phylogenetic tree, two of these clusters together with previous Brazilian σC ARV sequences, and one cluster (VII) that was novel for Brazilian strains. Antigenic analysis showed that there were amino acids within putative epitopes located on the surface of the receptor-binding region of the σC protein with a high degree of variability.4. The study confirmed the presence of ARV genetic variants circulating in commercial birds in Brazil, and according to the antigenic prediction, the possibility of antigenic variants appears to be high.

Genotypic characterization and molecular evolution of avian reovirus in poultry flocks from Brazil.

Avian reovirus (ARV) is one of the main causes of infectious arthritis/tenosynovitis and malabsorption syndrome (MAS) in poultry. ARVs have been disseminated in Brazilian poultry flocks in the last years. This study aimed to genotype ARVs and to evaluate the molecular evolution of the more frequent ARV lineages detected in Brazilian poultry-producing farms. A total of 100 poultry flocks with clinical signs of tenosynovitis/MAS, from all Brazilian poultry-producing regions were positive for ARV by PCR. Seventeen bird tissues were submitted to cell culture and ARV RNA detection/genotyping by two PCRs. The phylogenetic classification was based on σC gene alignment using a dataset with other Brazilian and worldwide ARVs sequences. ARVs were specifically detected by both PCRs from the 17 cell cultures, and σC gene partial fragments were sequenced. All these sequences were aligned with a total of 451 ARV σC gene data available in GenBank. Phylogenetic analysis demonstrated five well-defined clusters that were classified into lineages I, II, III, IV, and V. Three lineages could be further divided into sub-lineages: I (I vaccine, Ia, Ib), II (IIa, IIb, IIc) and IV (IVa and IVb). Brazilian ARVs were from four lineages/sub-lineages: Ib (48.2%), IIb (22.2%), III (3.7%) and V (25.9%). The Bayesian analysis demonstrated that the most frequent sub-lineage Ib emerged in the world around 1968 and it was introduced into Brazil in 2010, with increasing spread soon after. In conclusion, four different ARV lineages are circulating in Brazilian poultry flocks, all associated with clinical diseases. RESEARCH HIGHLIGHTS One-hundred ARV-positive flocks were detected in all main poultry-producing regions from Brazil. A large dataset of 468 S1 sequences was constructed and divided ARVs into five lineages. Four lineages/sub-lineages (Ib, IIb, III and V) were detected in commercial poultry flocks from Brazil. Brazilian lineages shared a low identity with the commercial vaccine lineage (I vaccine). Sub-lineage Ib emerged around 1968 and was introduced into Brazil in 2010.

Sequencing and phylogenetic analysis of partial S1 genes of avian orthoreovirus isolates in Shandong province during 2015-2017.

Outbreaks of avian orthoreovirus (ARV) infection with primary symptoms of arthritis/tenosynovitis syndrome have been occurring more frequently in broiler flocks in China in recent years. This study aimed to investigate the genetic characteristics of ARV field strains in broiler flocks exhibiting arthritis/tenosynovitis syndrome from 9 cities in Shandong province during 2015 to 2017. A total of 64 synovial and tendon samples were obtained from broilers with significant arthritis/tenosynovitis syndrome, and 21 ARV field strains were obtained. Phylogenetic analysis of the σC nt/aa sequences revealed that only 4 isolates were clustered in genotype I, including vaccine strains S1133, 1733, and most of the ARV field strains identified previously in China. Eleven and 6 ARV field isolates were identified in genotypes II and V, sharing 70.9 to 76.0% and 53.0 to 55.2% nt identities with the vaccine strains, respectively. Previous studies in China have not reported these 2 serotypes of field strains, and prevalence of these ARV variants may be increasing in Chinese broiler flocks. Results of this study suggest that large-scale investigation of epidemic ARV should be conducted to explore the genetic diversity of ARV field isolates in China.

Molecular characterization of avian reovirus causing tenosynovitis outbreaks in broiler flocks, Iran.

Avian reoviruses (ARVs) cause arthritis, tenosynovitis, retarded growth, and malabsorption syndrome. After a long time of effective prevention and low rates of viral arthritis/ tenosynovitis in Iran, outbreaks of tenosynovitis in broiler flocks have increased in recent years. Lameness, splay legs, high rate of cull birds, poor performance, uneven birds at harvest, and condemnation at processing cause huge economic losses. In this study, ARVs from the tendons of birds from 23 broiler flocks with marked tenosynovitis were characterized, and their genetic relationship was examined. Analysis of the amino acid sequence of Sigma C protein revealed that all ARVs detected in affected broiler flocks shared genetic homogeneity and this suggests that a single genotype is involved in recent outbreaks. This genotype, so-called "Ardehal strain", is grouped in cluster I with vaccine strains. The amino acid sequence similarity between Ardehal and vaccine strains, including S1133, 1733, and 2408 was less than 80%. As the outbreaks have occurred in progenies of vaccinated flocks, it is proposed here that the difference between vaccine and field strains might contribute to the failure of currently available vaccines to induce protective immunity against Ardehal strain and this led to widespread viral tenosynovitis in Iran.

Ultrasonographic and computed tomographic features of rice bodies in an Arabian horse with atlantal bursitis.

A 19-year-old castrated Arabian male horse presented for evaluation of a firm mass at the dorsal cervical region. Ultrasonography and computed tomography revealed multiple well defined fusiform structures within the atlantal bursa. Multiple glossy smooth, white to yellowish, flattened fusiform structures were removed surgically. These structures were composed of dense fibrin with some leukocytes and red blood cells. The imaging and histopathological features of these structures were similar to chronic 'rice bodies' reported in humans with bursitis or tenosynovitis. This is the first veterinary report describing the imaging features of 'rice bodies' in a horse with atlantal bursitis.

Retrospective Analysis of Turkey Arthritis Reovirus Diagnostic Submissions in Minnesota.

Turkey arthritis reovirus (TARV) causes tenosynovitis in turkeys, resulting in decreased profits for producers due to the increase in morbidity, mortality, and feed conversion ratio. There is limited information on TARV epidemiology, including the dynamics of diagnostic submissions to veterinary diagnostic laboratories. In this study, we retrospectively analyzed 719 cases of lameness in turkeys submitted to the Minnesota Veterinary Diagnostic Laboratory from March 2010 to May 2018. Almost all submissions were tendon pools, which were tested by virus isolation and/or real-time reverse transcription-polymerase chain reaction. Most of the submissions were from Minnesota. We found 52% of the submitted cases to be positive for TARV. The TARV-positive submissions increased considerably in the last few years. There was no statistical evidence that TARV diagnostic submissions were seasonal, although positive submissions were higher in January, April, July, and December. TARV-positive submissions also increased as flocks aged. In summary, we found that TARV submissions have increased in the last few years, have varied over time, and are correlated with age of the bird. This information is important guidance for conducting more studies to understand TARV infection dynamics.

Análisis retrospectivo de los casos de diagnóstico de artritis por reovirus en pavos en Minnesota. El reovirus de la artritis de los pavos (TARV) causa tenosinovitis en estas aves, lo que resulta en una disminución de las ganancias para los productores debido al aumento en la morbilidad, la mortalidad y la tasa de conversión alimenticia. Existe información limitada sobre la epidemiología del reovirus de los pavos, incluida la dinámica de los casos de diagnóstico enviados a los laboratorios de diagnóstico veterinario. En este estudio, se analizaron retrospectivamente 719 casos de cojeras en pavos enviados al Laboratorio de Diagnóstico Veterinario de Minnesota desde marzo del año 2010 hasta mayo del 2018. Casi todas los casos fueron muestras agrupadas de tendones, que se analizaron mediante aislamiento de virus y/o transcripción reversa y reacción en cadena de la polimerasa en tiempo real. La mayoría de los casos fueron de Minnesota. Se observó que el 52% de los casos presentados fueron positivos para reovirus de los pavos. Los casos positivos para artritis de los pavos por reovirus aumentaron considerablemente en los últimos años. No hubo evidencia estadística de que los casos de diagnóstico fueran estacionales, aunque los casos positivos fueron mayores en enero, abril, julio y diciembre. Las presentaciones positivas de la artritis de los pavos por reovirus también aumentaron a medida que las parvadas envejecían. En resumen, se observó que los casos de la artritis de los pavos por reovirus han aumentado en los últimos años, éstos han variado con el tiempo y están correlacionados con la edad del ave. Esta información es una guía importante para realizar más estudios para comprender la dinámica de la infección del reovirus causante de artritis en pavos.

Molecular detection of Mycoplasma synoviae and avian reovirus infection in arthritis and tenosynovitis lesions of broiler and breeder chickens in Santa Catarina State, Brazil.

Infectious arthritis or tenosynovitis in broiler and breeder chickens results in major loss of productivity because of reduced growth and downgrading at processing plants. The most common causative agents of avian infectious arthritis are the bacterium Mycoplasma synoviae and avian reoviruses (ARVs) (family Reoviridae, genus Orthoreovirus). In this study, we evaluated the occurrence of these two pathogens in arthritis or tenosynovitis lesions of broilers and breeder flocks in southern Brazil using molecular detection. Tissue sections from tibiotarsal joints with visible lesions from 719 broilers and 505 breeders were analysed using pathogen-specific polymerase chain reaction (PCR) assays. In breeders, 41.2% (n = 296) of lesions were positive for M. synoviae, 26.4% (n = 190) were positive for ARV, while co-infection was present in 12.2% (n = 88) of the samples. In broilers, 20.8% (n = 105) of lesions were positive for M. synoviae, 11.9% (n = 60) for ARV and 7.7% (n = 39) of these cases were positive for both pathogens. Post-mortem examination revealed lesions with varying degrees of gross pathological severity. Histopathological examination showed intense, diffuse lymphohistiocytic inflammatory infiltrates with heterophil accumulation, primarily in the synovial capsule and digital flexor tendon, in all samples. Improved strategies for early detection and control of these major avian pathogens are highly desirable for preventing the spread of infection and reducing economic losses in the poultry industry.

Pathogenicity and genomic characterization of a novel avian orthoreovius variant isolated from a vaccinated broiler flock in China.

Avian orthoreovirus (ARV) infections of broiler flocks cause arthritis/tenosynovitis syndrome and significant economic losses. ARV variants were detected in the USA and Canada. Viral arthritis/tenosynovitis syndrome has occurred frequently in China in recent years. In this study, a variant ARV strain associated with viral arthritis/tenosynovitis syndrome was isolated from broilers and designated as LY383. Genomic sequence and phylogenetic analysis of the σC nucleic acid and amino acid sequences revealed that the isolate was closely related to ARV field strains Reo/PA/Layer/01224B/14, Reo/PA/Broiler/1551/13, GA/14602/2014, GA/13569/2013 and GA/13542/2013, in cluster V, but distinct from most Chinese field strains or commercial vaccine strains. Experimental challenge showed that the isolate could cause arthritis/tenosynovitis syndrome in broilers, which possessed a high level of maternal antibodies induced by commercial ARV vaccines (S1133, 1733 and T98). Furthermore, viral nucleic acid could be detected in cloacal swabs of all challenged birds throughout the entire test from 5 dpi onward. These results suggest that a novel ARV genotype emerges and might become prevalent in broiler flocks in China. RESEARCH HIGHLIGHTS A variant avian orthoreovirus was isolated from a vaccinated broiler flock in North China. The ARV field strain was distinct from previous China-origin ARV isolates and vaccine strains. The current commercial ARV vaccine could not provide effective protection of broilers against the field isolate infection. These findings indicated that variant ARV field strains might become frequent in broiler flocks in China and effective measures should be conducted to prevent and control the disease.

Partial Molecular Characterization and Pathogenicity Study of an Avian Reovirus Causing Tenosynovitis in Commercial Broilers.

This study describes the molecular characterization of avian reoviruses (ARVs) isolated during an outbreak in commercial chickens between 2015 and 2016. In addition, a pathogenicity study of a selected ARV strain isolated from a field case of viral tenosynovitis in commercial broiler chickens was performed. On the basis of phylogenetic analysis of a 1088-bp fragment of the ARV S1 gene, the investigated sequences were differentiated into five distinct genotypic clusters (GCs), namely GC1, GC2, GC3, GC4, and GC6. Specific-pathogen-free (SPF) and commercial broiler chickens were challenged with the GC1 genetic type MK247011, at 14 days of age via the interdigital toe web. No significant effects in body weight gain and feed conversion were detected in both chicken types. The Δ interdigital web thickness was most severe at 4 days postchallenge (DPC) in both the SPF and broiler subgroups. The inflammation in SPF birds was slightly more severe compared with broilers. Neither mortality nor clinical signs occurred in the infected groups for the duration of the experiment, despite the presence of significant microscopic lesions in challenged birds. Microscopic changes of tenosynovitis became evident at 3 DPC, with the highest incidence and severity detected at 14 and 21 DPC, respectively. Seroconversion against ARV occurred 3 wk postchallenge, and the microscopic lesions detected in tendon and heart sections were highly compatible with those described in the field. Increased severity of tenosynovitis and epicarditis lesions were noted in the ARV-challenged groups compared with the control groups. Although SPF and broiler chickens showed comparable responses to the challenge with an ARV genetic variant, detected lesions were subclinical, denoting the limitations of our challenge approach. The age selected in this experiment possibly influenced the course of the infection. Data from this study highlight the genotypic diversity of isolates in California, and the outcome of the pathogenicity study can be used as a basis to improve protocols for pathogenicity studies to characterize ARV variants causing clinical disease in the field.

Caracterización molecular parcial y estudio de patogenicidad de un reovirus aviar que causa tenosinovitis en pollos de engorde comerciales. Este estudio describe la caracterización molecular de reovirus aviares (ARV) aislados durante un brote en pollos comerciales entre los años 2015 y 2016. Además, se realizó un estudio de patogenicidad de una cepa de reovirus seleccionada que fue aislada de un caso de campo de tenosinovitis viral en pollos de engorde comerciales. Con base en el análisis filogenético de un fragmento de 1088 pb del gene S1 de reovirus, las secuencias investigadas se diferenciaron en cinco grupos genotípicos distintos (GCs), denominados, GC1, GC2, GC3, GC4 y GC6. Aves libres de patógenos específicos (SPF) y pollos de engorde comerciales se desafiaron con el tipo genético GC1 MK247011 a los 14 días de edad a través de la membrana interdigital. No se detectaron efectos significativos en el aumento de peso corporal ni en la conversión de alimento en ambos tipos de aves. El grosor de la banda interdigital diferencial fue más severa a los cuatro días posteriores al desafío en las aves libres de patógenos específicos y en los pollos de engorde. La inflamación en las aves libres de patógenos específicos fue ligeramente más severa en comparación con los pollos de engorde. No se presentó mortalidad ni signos clínicos en los grupos infectados durante la duración del experimento, a pesar de la presencia de lesiones microscópicas significativas en las aves desafiadas. Los cambios microscópicos de la tenosinovitis se hicieron evidentes a los tres días postinoculación, con la mayor incidencia y severidad detectadas a los 14 y 21días postinoculación, respectivamente. La seroconversión para reovirus ocurrió tres semanas después del desafío, y las lesiones microscópicas detectadas en secciones de tendón y corazón fueron altamente compatibles con las descritas en el campo. El aumento en la severidad de las lesiones de tenosinovitis y epicarditis se observó en los grupos expuestos a reovirus aviar en comparación con los grupos de control. Aunque las aves libres de patógenos específicos y los pollos de engorde mostraron respuestas comparables ante el desafío con una variante genética de reovirus, las lesiones detectadas fueron subclínicas, lo que denota las limitaciones de nuestro enfoque de desafío. La edad seleccionada en este experimento posiblemente influyó en el curso de la infección. Los datos de este estudio resaltan la diversidad genotípica de los aislamientos en California y el resultado del estudio de patogenicidad se puede usar como base para mejorar los protocolos de los estudios de patogenicidad para caracterizar las variantes de reovirus que causan enfermedades clínicas en el campo.